Table 1.38a
Percent of AMI patients who received recommended hospital care,a Medicare beneficiaries, United States, 2002 and 2004
|
|
2004 |
2002 |
Population group |
Percent |
Standard error |
Percent |
Standard error |
Total |
85.6 |
0.2 |
80.0 |
0.2 |
Gender |
Male |
86.1 |
0.2 |
81.1 |
0.2 |
Female |
84.9 |
0.2 |
78.6 |
0.2 |
Race |
White |
86.0 |
0.2 |
80.5 |
0.2 |
Black |
82.7 |
0.6 |
76.5 |
0.6 |
Hispanic |
80.2 |
1.1 |
71.4 |
1.2 |
Native American |
85.5 |
1.6 |
80.0 |
1.9 |
Asian |
80.0 |
1.5 |
79.7 |
1.5 |
Age |
Under 65 |
85.7 |
0.4 |
DNA |
DNA |
65-74 |
87.0 |
0.2 |
DNA |
DNA |
75-84 |
85.5 |
0.3 |
DNA |
DNA |
85 and over |
83.2 |
0.4 |
DNA |
DNA |
a Recommended hospital care for AMI includes administrations of aspirin and beta-blocker within 24 hours of hospital arrival and at discharge, receiving a prescription of angiotensin converting enzyme (ACE) inhibitor at discharge for patients with left ventricular systolic dysfunction, and giving smoking cessation counseling for smoking patients.
DNA - Data have not been analyzed.
Source: Centers for Medicare & Medicaid Services, Medicare Quality Improvement Organization Program.
Return to Contents